Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)

INTRODUCTION: Post-marketing surveillance activities (namely pharmacovigilance) are crucial to favor the early detection of unexpected adverse events (AEs) and/or serious adverse reactions (SAEs). Indeed, spontaneous reporting of AEs has been demonstrated to underestimate the number of events in dif...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Palleria, Caterina, Iannone, Luigi, Leporini, Christian, Citraro, Rita, Manti, Antonia, Caminiti, Maurizio, Gigliotti, Pietro, Grembiale, Rosa Daniela, L’Andolina, Massimo, Muccari, Giuseppe, Naturale, Maria Diana, Olivo, Domenico, Pagano Mariano, Giuseppa, Pellegrini, Roberta, Varcasia, Giuseppe, Abdalla, Karim, Russo, Emilio, Ursini, Francesco, De Sarro, Giovambattista
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6200211/
https://ncbi.nlm.nih.gov/pubmed/30356301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0205134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados